Fig. 1From: Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapyFlow diagram of enrollment, allocation, follow-up, and analysis of patients included in phase 1b (a), phase 2b (b), and phase 2 (c). * one patient was withdrawn for the occurrence of grade 4 neutropeniaBack to article page